IDiyas

For the Inventor, By the Inventor

Salem, CT, United States of America

John Eugene Macor

USPTO Granted Patents = 29 

Average Co-Inventor Count = 1.5

ph-index = 9

Forward Citations = 292(Granted Patents)


Location History:

  • Mystic, CT (US) (1991 - 1992)
  • New York, NY (US) (1996 - 1997)
  • Groton, CT (US) (1997)
  • Penfield, NY (US) (1997 - 2001)
  • Salem, CT (US) (1996 - 2002)

Company Filing History:

goldMedal28 out of 4,455 
 
Pfizer Corporation
 patents
silverMedal1 out of 832,718 
Other
 patents

Years Active: 1991-2002

Loading Chart...
29 patents (USPTO):Explore Patents
1. 6465500 - Indole derivatives as 5-HT1 agonists (2002-10-15),
2. 6436957 - Indole derivatives as 5-HT1 agonists (2002-08-20),
3. 6410739 - Indole derivatives as 5-HT1 agonists (2002-06-25),
4. 6387941 - Indole derivatives as 5-HT1 agonists (2002-05-14),
5. 6387937 - Indole derivatives (2002-05-14),
6. 6380233 - Indole derivatives as 5-HT1 agonists (2002-04-30),
7. 6255306 - 4-indole derivatives as serotonin agonists and antagonists (2001-07-03),
8. 6166020 - Aryl and heteroaryl alkoxynaphthalene derivatives (2000-12-26),
9. 6150388 - Indole derivatives as 5-HT1 agonists (2000-11-21),
10. 6093822 - 5-arylindole derivatives (2000-07-25),
11. 5994352 - 5-arylindole derivatives (1999-11-30),
12. 5942524 - 5-arylindole derivatives (1999-08-24),
13. 5886008 - 5-arylindole derivatives (1999-03-23),
14. 5849739 - 5-arylindole derivatives (1998-12-15),
15. 5747501 - Indole derivatives (1998-05-05),

Title: John Eugene Macor: A Pioneering Inventor in Pharmaceutical Innovations

Introduction: John Eugene Macor, based in Salem, CT, is an accomplished inventor known for his significant contributions to the field of pharmaceuticals. With an impressive portfolio of 29 patents, Macor has made notable advancements, particularly in developing compounds that impact serotonin receptors, demonstrating his expertise in medicinal chemistry and drug design.

Latest Patents: Among his latest innovations, Macor has focused on indole derivatives as 5-HT1 agonists. This work highlights his ongoing research and dedication to creating novel therapeutic agents aimed at treating various neurological and psychiatric conditions.

Career Highlights: Throughout his career, John Eugene Macor has worked with Pfizer Corporation, a leading global pharmaceutical company. His time at Pfizer allowed him to collaborate with other talented scientists and contribute to breakthrough innovations in drug development.

Collaborations: Macor's work has also been enriched through collaborations with notable colleagues, including Martin James Wythes and Bertrand Leo Chenard. These partnerships have fostered a creative environment for brainstorming and developing pioneering pharmaceutical solutions.

Conclusion: John Eugene Macor's extensive patent portfolio and collaborations reflect his dedication to innovation in the pharmaceutical industry. His work continues to inspire upcoming inventors and reinforces the importance of research and development in advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…